# Mass Balance Recovery, Pharmacokinetics and Metabolite Profile and Identification of [14C]AZD7594

> **NCT04002427** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 6 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Intravenous Infusion
- **DRUG:** Inhaled dose

## Key facts

- **NCT ID:** NCT04002427
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-11
- **Primary completion:** 2019-07-05
- **Final completion:** 2019-07-05
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2019-07-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04002427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04002427, "Mass Balance Recovery, Pharmacokinetics and Metabolite Profile and Identification of [14C]AZD7594". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04002427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*